All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for time and travel may be provided. You do not need to be a current patient of Atlanta Allergy & Asthma to participate in a research study.

---

Participants Needed for Peanut Allergy Study: Epicutaneous Peanut Immunotherapy

Qualifications to be considered for this study:

• Children ages 4 to 11
• Physician -diagnosed peanut allergy or children with a well-documented medical history of Ige-mediated reaction(s) after ingestion with peanut. (Children with a history of anaphylaxis, including severe anaphylaxis to peanut will be eligible)
• Peanut-specific  positive peanut skin prick test and peanut blood test Not currently on immunotherapy for any allergen (including environmental & insect allergy)
• No monoclonal antibody therapy within 6 months of screening
• No uncontrolled persistent asthma

To learn more, please contact Martha Coggins at our Stockbridge Research facility.

Phone: 770.996.5354

Email: [email protected]

Participants Needed for Chronic Spontaneous Urticaria (CSU) Study:

Qualifications to be considered for this study:

• Ages 18 and up
• CSU duration greater than 6 months
• CSU inadequately controlled by H1-antihistamines
• Documentation of hives within 3 months before screening
• Willing to complete a urticaria patient daily diary for the duration of the study
• Participants cannot have monoclonal antibody treatment within 4 months of screening

To learn more, please contact Martha Coggins at our Stockbridge Research facility.

Phone: 770.996.5354

Email: [email protected]

Participants Needed for Peanut Allergy Study:

Qualifications to be considered for this study:

• Ages 6 to 55
• Documented medical history of allergy to peanuts or peanut containing foods
• Participants must be able to receive injections (study treatment)
• No uncontrolled asthma
• No monoclonal antibody treatment within 6 months of screening

To learn more, please contact Janet Plumley at our Kennestone Research facility.

Phone: 770.592.4210

Email: [email protected]